Biopharmacological composition comprising components produced and / or secreted by mesenchymal stem cells (MSC) that allow the recovery of tissue regenerative capacity, in a situation of hepatic steatosis or where the endogenous regeneration capacity of liver tissue is inhibited
Más información
DOI: |
201502971 |
Notas: | patent pending |